Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease

In Vivo

Volumn 21, Issue 5, 2007, Pages 757-770

  Golias, C H ^a   Tsoutsi, E ^a   Matziridis, A ^b   Makridis, P ^b   Batistatou, A ^c   Charalabopoulos, K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Department of Cardiology   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

CD44 cell adhesion molecule; Cell adhesion molecules; Endocarditis; ICAM 1; Immunoglobulin gene superfamily; Myocarditis; Review; Selections

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

BACTEREMIA; BACTERIAL ENDOCARDITIS; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART DISEASE; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MONOCYTE; MYOCARDITIS; NONHUMAN; PERICARDITIS; REVIEW; SHEAR STRESS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS SANGUINIS; VASCULAR ENDOTHELIUM; VENULE; ANIMAL; CLASSIFICATION; GENETICS; IMMUNOLOGY; LEUKOCYTE; METABOLISM; SOLUBILITY;

ANIMALS; CELL ADHESION MOLECULES; HEART DISEASES; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; LEUKOCYTES; SOLUBILITY;

EID: 35648981552     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Carreno MP, Rousseau Y and Haeffner-Cavaillon N: Cell adhesion molecules and the immune system. Allerg Immunol (Paris) 27(4): 106-110, 1995.
2. Hillis GS and MacLeod AM: Integrins and disease. Clin Sci (Lond) 91(6): 639-650, 1996.
3. Mareckova Z, Heller S and Horky K: Cell adhesion molecules and their role in pathophysiologic processes. Vnitr Lek 45(1): 46-50, 1999.
4. Rojas AI and Ahmed AR: Adhesion receptors in health and disease. Crit Rev Oral Biol Med 10(3): 337-358, 1999.
5. Jaitovich A and Etcheverry GJ: Adhesion molecules. Their role in cardiovascular physiopathology. Medicina (B Aires) 64(5): 455-462, 2004.
6. Charalabopoulos K, Binolis J and Karkabounas S: Adhesion molecules in carcinogenesis. Exp Oncol 24: 249-257, 2002.
7. Batistatou A, Makrydimas G, Zagoriannakou N, Zagoriannakou P, Nakanishi Y, Agnantis N, Hirohashi S and Charalabopoulos K: Expression of dysadherin and E-cadherin in trophoblastic tissue in normal and abnormal pregnancies. Placenta 28(5-6): 590-592, 2006.
8. Krieglstein CF. and Granger DN: Adhesion molecules and their role in vascular disease. Am J Hypertension 14(6): 44S-54S, 2001.
9. Takahashi K, Noto K, Okumura K and Kira S: Structures and functions of adhesion molecules-involvement of adhesion molecules in the pathogenesis. Nippon Rinsho 50(11): 2816-2823, 1992.
10. Pafilis J, Batistatou A, Iliopoulou A, Tsanou B, Bakogiannis A, Dassopoulos D and Charalabopoulos K: Expression of adhesion molecules during the normal pregnancy. Cell Tissue Res 329(1): 1-11, 2007.
11. Batistatou A, Charalabopoulos A, Scopa C, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ and Charalabopoulos K: Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Archiv 448(6): 763-767, 2006.
12. Kyzas P, Batistatou A, Stefanou D, Nakanishi Y, Agnantis NJ, Hirohashi S and Charalabopoulos K: Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 30: 185-193, 2006.
13. Horvathova M and Ferencik M: The role of adhesion molecules in the immune system. Bratisl Lek Listy 101(3): 138-145, 2000.
14. Jang Y, Lincoff AM, Plow EF and Topol EJ: Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24(7): 1591-1601, 1994.
15. Hope SA and Meredith IT: Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J 33(8): 380-386, 2003.
16. Georgolios A, Batistatou A and Charalabopoulos K: Integrins in head and neck squamous cell carcinoma. A review article of the current literature. Cell Adhesion Commun 12: 1-8, 2005.
17. Georgolios A, Batistatou A, Charalabopoulos A, Manolopoulos L and Charalabopoulos K: The role of CD44 adhesion molecule in oral cavity cancer. Exp Oncol 28(2): 94-98, 2006.
18. Gonzalez-Amaro R, Diaz-Gonzalez F and Sanchez-Madrid F: Adhesion molecules in inflammatory diseases. Drugs 56(6): 977-988, 1998.
19. Belohlavkova S and Simak J: Adhesion receptors of the vascular endothelium and their role in acute inflammation. Cesk Fysiol 48(2): 51-61, 1999.
20. Yong K and Khwaja A: Leucocyte cellular adhesion molecules. Blood Rev 4(4) : 211-225, 1990.
21. Spertini O: Regulation of leukocyte migration by adhesion molecules. Schweiz Med Wochenschr 126(45): 1926-1934, 1996.
22. Tailor A and Granger DN: Role of adhesion molecules in vascular regulation and damage. Cun Hypertens Rep 2(1): 78-83, 2000.
23. Bevilacqua MP. and Nelson RM: Selectins. J Clin Invest 91: 379-387, 1993.
24. Rosen ND and Bertozzi CR: The selectins and their ligands. Cur Opinion Cell Biol 6: 663-673, 1994.
25. Tedder TF, Steeber DA, Chen A and Engel P: The selectins: vascular adhesion molecules. FASEB 9: 866-873, 1995.
26. Von Adrian UH, Berger EM, Ramezani L, Chambers JD, Ochs HD, Harlan JM, Paulson JC, Etzioni A, and Arfors KE: In vivo behavior of neutrophils from two patients with distinct inherited LAD syndromes. J Clin Invest 91: 2893-2897, 1993.
27. Gearing AJ and Newman W: Circulating adhesion molecules in disease. Immunol Today 14: 506-512, 1993.
28. McEver RP: GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 45: 156-161, 1991.
29. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS and Gimbrone MJ: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84: 9238-9242, 1987.
30. Rosen SD, Bertozzi CR: The selectins and their ligands. Curr Opin Cell Biol 6(5): 663-673, 1994.
31. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ and Cashman SJ: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Annals NY Acad Sci 667: 324-331, 1992.
32. Martin S, Lampeter EF, Kolb H: A physiological role for circulating adhesion molecules? Immunol Today 15(3): 141, 1994.
33. Fries JW, Williams AJ, Atkins RC, Newman W, Lipscomb MF and Collins T: Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 143: 725-737, 1993.
34. Foxall C, Watson SR. Dowbenko D, Fennie C, Lasky LA, Kiso M, Hasegawa A, Asa D and Brandley BK: The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J Cell Biol 117: 895-902, 1992.
35. Patel KD, Moore KL, Nollert MU and McEver RP: Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J Clin Invest 96: 1887-1896, 1995.
36. Holness C and Simmons DL: Structural motifs for recognition and adhesion in members of the immunoglobulin superfamily. J Cell Sci 107: 2065-2070, 1994.
37. Klein RM, Breuer R, Mundhenke M, Schwartzkopff B and Strauer BE: Circulating adhesion molecules (cICAM-1, 1cVCAM-1) in patients with suspected inflammatory heart muscle disease. Z Kardiol 87(2): 84-93, 1998.
38. Zimmermann GA, Prescott SM and McIntyre TM: Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13(3): 93-100, 1992.
39. Shimizu Y: Lymphocyte interactions with endothelial cells. Immunol Today 13: 106-112, 1992.
40. Dustin ML, Rothlein R, Bhan AF, Dinarello CA and Springer TA: Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245-254, 1986.
41. Panés J, Perry MA, Anderson DC, Manning A, Leone B, Cepinskas G, Rosenbloom CL, Miyasaka M, Kvietys PR and Granger DN: Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 269: H1955-H1964, 1995.
42. Henninger DD, Panés J, Eppihimer M, Russell J, Gerritsen M, Anderson DC and Granger DN: Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158: 1825-1832, 1997.
43. Georgolios A, Batistatou N, Bonitsis N, Stagikas D, Manolopoulos L and Charalabopoulos K: The role of intercellular adhesion molecule-1 in head and neck cancer. Exp Oncol 28(4): 270-274, 2006.
44. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F and Weissmann G: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89(21): 9991-9995, 1992.
45. Chyczewski L and Debek W:Endothelial cell activation in shock. Rocz Akad Med Bialymst 40(1): 1-12, 1995.
46. Nakae H, Endo S, Inada K, Takakuwa T and Kasai T: Changes in adhesion molecule levels in sepsis. Res Commun Mol Pathol Pharmacol 91(3): 329-338, 1996.
47. Hess DC, Bhutwala T, Sheppard JC, Zhao W and Smith J: ICAM-1 expression on human brain microvascular endothelial cells. Neurosci Lett 168 (1-2): 201-204, 1994.
48. De Fougerolles A.R, Stacker S.A, Schwarting R and Springer TA: Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 174: 253-267, 1991.
49. Nortamo P, Renkonen RLi, Timonen T, Pieta J, Patarroyo M and Gahmberg CG: The expression of human intercellular adhesion molecule 2 is refractory to inflammatory cytokines. Eur J Immunol 21: 2629-2632, 1991.
50. Cartwright JE, Whitley GS and Johnstone A: The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. Exp Cell Res 217: 329-335, 1995.
51. Cunningham AC and Kirby JA: Regulation and function of adhesion molecules expression by human alveolar epithelial cells. Immunology 86: 279-286, 1995.
52. Holness C, Bates PA, Little AJ, Buckley CD, McDowall A, Bossy D, Hogg N and Simmons DL: Analysis of the binding site on LCAM-3 for the leukocyte integrin LEA-1. J Biol Chem 220: 877-884, 1995.
53. Acevedo A, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Gonzalez-Amaro R and Sanchez-Madrid F: Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol 143(3): 774-783, 1993.
54. Campanero MR, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Hernandez-Caselles T, Craig A, Pulido R and Sanchez-Madrid F: ICAM-3 interacts with LEA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 123(4): 1007-1016, 1993.
55. Doussis-Anagnostopoulou I, Kaklamanis L, Cordell J, Jones M, Turley H, Pulford K, Simmons D, Mason D and Gatter K: ICAM-3 expression on endothelium in lymphoid malignancy. Am J Pathol 143(4): 1040-1043, 1993.
56. Albelda SM, Muller WA, Buck CA and Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 114: 1059-1068, 1991.
57. Muller WA, Weigl SA, Deng X and Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178(2): 449-460, 1993.
58. Vaporciyan A: Involvement of PECAM-1 in neutrophil recruitment in vivo. Science 262: 1580-1582, 1993.
59. De Lisser HM, Newman PJ and Albelda SM: Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15: 490-495, 1994.
60. Streete PR, Berg EL, Rouse BTN, Bargatze RF and Butcher EC: A tissue-specific endothelial cell molecule involved in leukocyte homing. Nature 331: 41-46, 1988.
61. Briskin MJ, McEvoy LM and Butcher EC: MadCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA. Nature 363: 461-464, 1993.
62. Stauder R and Gunthert U: CD 44 isoforms. Impact on lymphocyte activation and differentiation. The Immunologist 3: 78-83, 1995.
63. Fox S.B, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A and Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54: 4539-4546, 1994.
64. Guntert U, Stauder R, Mayer B, Terpe HJ, Finke L and Friedrichs K: Are CD44 variant isoforms involved in human tumor progression? Cancer Surveys 24: 19-42, 1995.
65. Ruiz F, Schwarzler C and Gunthert U: CD 44 isoforms during differentiation and development. BioEssays 17: 17-24, 1995.
66. Rudzki Z, Jothy S: CD44 and the adhesion of neoplastic cells. Mol Pathol 50(2): 57-71, 1997.
67. Camp, RL, Scheynius A, Johansson C and Pure E: CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178: 497-507, 1993.
68. Mikecz K, Brennan FR, Kim JH and Glant T: T Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1: 558-563, 1995.
69. DeGrendele HC, Estess P and Siegelman MH: Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278(5338): 672-675, 1997.
70. Stoop R, Kotani H, McNeish JD, Otterness G and Mikecz K: Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. Arthritis Rheum 44: 2922-2931, 2001.
71. Carlos TM and Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101, 1994.
72. Khan AI, Landis RC and Malhotra R: L-selectin ligands in lymphoid tissues and models of inflammation. Inflammation 27: 265-280, 2003.
73. Ebnet K and Vestweber D: Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem Cell Biol 112: 1-23, 1999.
74. Siegelman MH, DeGrendele HC and Estess P: Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukocyte Biol 66: 315-321, 1999.
75. Sconocchia G, Titus JA and Segal DM: CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol 153: 5473-5481, 1994.
76. Pericle F, Sconocchia G, Titus JA and Segal DM: CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol 157: 4657-4663, 1996.
77. Si-Tahar M, Sitaraman S, Shibahara T and Madara JL: Negative regulation of epithelium-neutrophil interactions via activation of CD44 Am J Physiol Cell Physiol 280: C423-432, 2001.
78. Reinhardt P H and Kubes P: Differential leukocyte recruitment from whole blood via endothelial adhesion molecules under shear conditions. Blood 92: 4691-4699, 1998.
79. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM and Noble PW: Resolution of lung inflammation by CD44 Science 296: 155-158, 2002.
80. Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, Ruffell B, Johnson P and Kubes P: Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 173: 7594-7601, 2004.
81. Fujisaki, T, Tanaka Y, Fujii K, Mine S, Saito K, Yamada S, Yamashita U, Irimura T and Eto S: CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 59: 4427-4434, 1999.
82. Kubes P, Niu XF, Smith CW, Kehrli ME Jr, Reinhardt PH and Woodman RC: A novel beta1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 9: 1103-1111, 1995.
83. Steeber DA, Venturi GM and Tedder TF: A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol 26(1): 9-12, 2005.
84. Nandi A, Estess P and Siegelman M: Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20(4): 455-465, 2004.
85. Granger DN and Kubes P: The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55: 662-675, 1994.
86. Lawrence MB and Springer TA: Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65: 859-873, 1991.
87. Lefer AM: Significance of lipid mediators in shock states. Circ Shock 27: 3-12, 1989.
88. Eriksson EE, Wer J, Guo Y, Thoren P and Lindbom L: Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte-endothelium interactions in the mouse aorta. Circ Res 86: 526-533, 2000.
89. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ and Cashman SJ: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathologic significance. Ann NY Acad Sci 667: 324-331, 1992.
90. Leewenberg JFM, Smeets EF, Neefjes J Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ and Buurman WA: E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. J Immunol 77: 543-549, 1992.
91. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J and Matthay M: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150: 644-654, 1993.
92. Pigott R, Dillon LP, Hemingway IH and Gearing AJH: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine-activated endothelial cells. Biochem Biophys Res Commun 187: 584-589, 1992.
93. Blann AD, McCollum CN, Steiner M, Jayson MI: Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. Immunol Today 16(5): 251-252, 1995.
94. Bayer AS and Scheld WM: Endocarditis and intravascular infections. In: Mandell, Douglas, and Bennett's Principals and Practices of Infectious Diseases. Mandell GL, Bennett JE, Dolin M (eds.). 5th ed. Philadelphia, PA: Churchill Livingstone, pp. 857-902, 2000.
95. Cowley HC, Heney D, Gearing AJH, Hemingway I and Webster NR: Increased circulating adhesion molecule concentrations in patients with systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 22: 651-657, 1994.
96. Sessler CN, Windsor AC and Schwartz M: Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 151: 1420-1427, 1995.
97. Veltrop MH, Thompson J and Beekhuizen H: Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium infected human vascular endothelial cells. Infect Immun 69(5): 2797-2807, 2001.
98. Norris P, Poston RN, Thomas DS, Thornhil M, Hawk J and Haskard DO: The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol 96: 763-770, 1991.
99. Söderquist, Sundqvist and Vikerfors: Adhesion molecules (E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in sera from patients with Staphylococcus aureus bacteraemia with or without endocarditis. Clin Exp Immunol 118(3) : 408-411, 1999.
100. Muller AM, Cronen C, Kupferwasser LI, Oelert H, Muller KM and Kirkpatrick CJ: Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis. J Pathol 191(1): 54-60, 2000.
101. Carlos TM and Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101, 1994.
102. Veltrop MH, Beekhuizen H: Monocytes maintain tissue factor activity after cytolysis of bacteria-infected endothelial cells in an in vitro model of bacterial endocarditis. J Infect Dis 186(8): 1145-1154. 2002.
103. Korkmaz S, Ileri M, Hisar I, Yetkin E and Kosar F: Increased levels of soluble adhesion molecules, E-selectin and P-selectin, in patients with infective endocarditis and embolic events. Eur Heart J 22(10): 811-812, 2001.
104. Woodruff JF. Viral myocarditis: A review: Am J Pathol 101: 425-484, 1980.
105. Liu PP and Mason JW: Advances in the understanding of myocarditis. Circulation 104: 1076-1082, 2001.
106. Liu PP and Opavsky MA: Viral myocarditis: Receptors that bridge the cardiovascular with the immune system? Circ Res 86(3): 253-254, 2000.
107. Lange LG and Schreiner GF: Immune mechanisms of cardiac disease. N Engl J Med 330(16): 1129-1135, 1994.
108. Seko Y, Yamazaki T, Shinkai Y, Yagita H, Okumura K, Naito S, Imataka K, Fujii J and Yazaki Y: Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy. Jpn Circ J 56(10): 1062-1072, 1992.
109. Noutsias M, Seeberg B, Schultheiss HP and Kühl U: Expression of cell adhesion molecules in dilated cardiomyopathy. Circulation 99: 2124-2131, 1999.
110. Sprent J, Thougn DF and Sun S: Factors controlling the turnover of T memory cells. Immunol Rev 156: 79-85, 1997.
111. Klein RM, Breuer R, Mundhenke M, Schwartzkopff B and Strauer BE: Circulating adhesion molecules (cICAM-1, IcVCAM-1) in patients with suspected inflammatory heart muscle disease. Z Kardiol 87(2): 84-93, 1998.
112. Hokibara S, Takamoto M, Isobe M and Sugane K: Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice. Clin Exp Immunol 114(2): 236-244, 1998.
113. Pummerer CL, Grassl G, Sailer M, Bachmaier KW, Penninger JM and Neu N: Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. Lab Invest 74: 845-852, 1996.
114. Wang Y, Afanasyeva M, Hill SL and Rose NR: Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity 31:151-162, 1999.
115. Camacho SA, Heath WR, Carbone FR, Sarvetnick N, LeBon A, Karlsson L, Peterson PA and Webb SR: A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol 2: 523-529, 2001.
116. dos Santos PVA, Roffê E, Santiago HC, Torres RA, Marino APMP, Paiva CN, Silva AA, Gazzinelli RT and Lannes-Vieira J: Prevalence of CD8 T-cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1 (High) VLA-4(High) activation phenotype and expression of IFN-g-inducible adhesion and chemoattractant molecules. Microbes Infect 3: 971-984, 2001.
117. Seko Y, Yagita H, Okumura K and Yazaki Y: Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Pathol 180: 450-454, 1996.
118. Benvenuti LA, Higuchi ML and Reis MM: Upregulation of adhesion molecules and class I HLA in the myocardium of chronic chagasic cardiomyopathy and heart allograft rejection, but not in dilated cardiomyopathy. Cardiovasc Pathol 9:111-117, 2000.